Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Why Should Site Agility Be Your Next Competitive Advantage?
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.
Scaling Outsourced Clinical Trial Services
Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.
From Months To Hours: MMC Medical's EDC Revolution
Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.
ICH E6(R3) Annex 2: Navigating GCP Requirements For Decentralized Trials
Implementing decentralized components or real-world data requires proactive alignment with updated GCP standards for data access, remote consent, and multi-stream investigator oversight.

Modernizing Clinical Research With Patient-Centric Digital Data Collection
2/25/2025

Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.
Obesity Clinical Research: Patient Recruitment Challenges
1/15/2026

Obesity trials face enrollment hurdles. Learn how data-driven insights, patient-first strategies, and decentralized models can break barriers, ease burden, and accelerate timelines.
FDA Fast-Tracked Clinical Trial
7/9/2026

Deconstruct the enrollment bottleneck in an ophthalmic gene therapy trial, discovering how point-of-need pre-screening cuts site activation delays and accelerates clinical development timelines.
Designing More Representative Trials Through Strategic Planning
5/28/2025

Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.
Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays
9/25/2025

Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

ecoScout For Meetings

Discover Scout's strategies for elevated, eco-friendly face-to-face and hybrid events. ecoScout for Meetings takes a comprehensive approach to minimizing carbon emissions and maintaining the highest standards of quality and service.
Data Lifecycle At CRC

A structured data lifecycle from protocol design to database lock keeps trial data clean, compliant, and ready for regulatory submission.
The Starting Point For Trial Transparency

Clinical trial sponsors can make results easier to find, understand, and share. Examine how participants stay informed while reducing manual distribution, tracking, and multilingual access challenges.
Adherence Monitoring Solutions: Choose The Right Level Of Support

Help your study team curb trial costs and delays by monitoring adherence in near real time. These tools automate reporting and issue alerts to maximize data capture and regulatory readiness.
First-In-Human To Proof-Of-Concept: The DVCR Continuity Model

With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.